Subscribe to RSS
DOI: 10.1055/a-1505-1046
Relationship between clinical signs and hormonal analytical findings in bitches with lactatio sine graviditate
Beziehungen zwischen klinischen Symptomen und hormonanalytischen Befunden bei Hündinnen mit Lactatio sine graviditate![](https://www.thieme-connect.de/media/10.1055-s-00034911/202103/lookinside/thumbnails/10-1055-a-1505-1046-1.jpg)
Abstract
Objective Lactatio sine graviditate of the bitch can become clinically relevant in particularly severe manifestations. The aim of the study was to relate the hormone pattern consisting of progesterone (P4), estradiol 17β (E2) and prolactin to the time of occurrence of lactatio sine graviditate in the course of metoestrus and anoestrus as well as to its symptomatology.
Material and methods Sixty-eight bitches with apparent lactatio sine graviditate were divided into 3 groups according to their cycle status. All bitches were examined for gynaecological findings. Furhtermore, their blood progesterone, oestrogen, and prolactin concentrations were determined and compared with the 133-day hormone profile of 7 control animals.
Results Lactatio sine graviditate occurring in early metoestrus was characterised more by a shifted P4:E2 ratio than by hyperprolactinaemia. Overall, the prolactin concentration in the peripheral blood was significantly increased. Analysis of the individual cases revealed that hyperprolactinaemia was present to varying degrees. It could be detected in almost all bitches that showed full symptomatology at the end of metoestrus or at the beginning of anoestrus. Only then clinical signs correlated with an increased prolactin concentration in the peripheral blood. In most cases, the estradiol-17β concentration was within the reference range.
Conclusion and clinical relevance The study indicates that the administration of prolactin inhibitors alone is not indicated in all cases of lactatio sine graviditate and that the timepoint of onset of the clinically relevant symptoms and the current prolactin level should be taken into account in the treatment of affected bitches.
Zusammenfassung
Gegenstand und Ziel Die Lactatio sine graviditate der Hündin kann in besonders starker Ausprägung klinische Relevanz erlangen. Ziel der Studie war, das Hormonmuster, bestehend aus Progesteron (P4), Östradiol 17β (E2) und Prolaktin, in Beziehung zum Zeitpunkt des Auftretens einer Lactatio sine graviditate im Verlauf des Met- und Anöstrus sowie zu deren Symptomatik zu setzen.
Material und Methoden Achtundsechzig Hündinnen mit klinischer Lactatio sine graviditate wurden entsprechend ihrem Zyklusstatus in 3 Gruppen eingeteilt. Bei jeder Hündin erfolgten eine eingehende gynäkologische Untersuchung sowie eine Bestimmung der Progesteron-, Östrogen- und Prolaktin-Konzentrationen im Blut. Die Hormonkonzentrationen der Probanden wurden mit dem 133-Tage-Hormonprofil von 7 Kontrolltieren verglichen.
Ergebnisse Eine im frühen Metöstrus auftretende Lactatio sine graviditate war mehr von einem verschobenen P4:E2-Verhältnis geprägt als von einer Hyperprolaktinämie. Insgesamt betrachtet war der Prolaktingehalt im peripheren Blut signifikant erhöht. Bei der Analyse der Einzelfälle fiel auf, dass eine Hyperprolaktinämie in unterschiedlicher Ausprägung vorlag. Bei nahezu allen Hündinnen, die die volle Symptomatik am Ende des Metöstrus, zu Beginn des Anöstrus aufwiesen, ließ sich eine Hyperprolaktinämie feststellen. Nur dann korrelierten die klinischen Zeichen mit einer erhöhten Prolaktinkonzentration im peripheren Blut. In den meisten Fällen lag die Östradiol-17β-Konzentration im Referenzbereich.
Schlussfolgerung und klinische Relevanz Die Untersuchung gibt einen Hinweis darauf, dass eine alleinige Antiprolaktingabe nicht in allen Fällen einer Lactation sine graviditate angezeigt ist, sondern der Zeitpunkt des Auftretens der klinisch relevanten Symptome und der aktuelle Prolaktinwert im Therapiekonzept Berücksichtigung finden sollten.
Supplementary material
- Supplementary material is available under https://dx.doi.org/10.1055/a-1505-1046
- Supplementary material
Publication History
Received: 22 February 2021
Accepted: 10 May 2021
Article published online:
22 June 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Concannon PW, Hansel W, Visek WJ. The ovarian cycle of the bitch: plasma estrogen, LH and progesterone. Biol Reprod 1975; 13: 112-121
- 2 Gräf KJ. Serum oestrogen and prolactin concentrations in cyclic, pregnant and lactating beagle dogs. J Reprod Fertil 1978; 52: 9-14
- 3 Reimers TJ, Phemister RD, Niswender GD. Radioimmunological measurement of follicle stimulating hormone and prolactin in the dog. Biol Reprod 1978; 19: 673-679
- 4 Concannon PW, Altszuler N, Hampshire J. et al. Growth hormone, prolactin and cortisol in dogs developing mammary modules and an acromegaly-like appearance during treatment with medroxyprogesterone acetate. Endrocinology 1980; 106: 1173-1175
- 5 Kooistra HS, Okkens AC. Secretion of prolactin and growth hormone in relation to ovarian activity in the dog. Reprod Domest Anim 2001; 36: 115-119
- 6 Corrada Y, Castex G, Sosa Y. et al. Secretory patterns of prolactin in dogs: circannual and ultradian rhythmus. Reprod Domest Anim 2003; 38: 219-223
- 7 Günzel-Apel AR, Zabel S, Bunck CF. et al. Concentrations of progesterone, prolactin and relaxin in the luteal phase and pregnancy in normal and short cycling German Shepherd dogs. Theriogenology 2006; 66: 1431-1435
- 8 Kowalewsky MP, Mason JI, Howie AF. et al. Characterization of the canine 3 beta-hydroxysteroid-dehydrogenate and its expression in the corpus luteum during diestrus. J Steroid Biochem Mol Biol 2006; 101: 254-262
- 9 Chakraborty PK. Reproductive hormone concentrations during estrus, pregnancy and pseudopregnancy in the laborador bitch. Theriogenology 1987; 27: 827-840
- 10 Gerres S, Höveler R, Evers P. et al. Investigation of the role of progesteron (P4) in the endocrine control of overt pseudopregnancy in the bitch, application of an antigestagen. Proceedings of the 11th International Congres of Animal Reproduction and Artifical Insemination; 26–30 06/1988. Dublin (IE): 90
- 11 Gobello C. Dopamine agonists, anti-progestins, anti-androgens, longterm-release GnRH agonists and anti-estrogens in canine reproduction: A review. Theriogenology 2006; 66: 1560-1567
- 12 Voith VL. Behaviorial disorders. In: Ettinger SJ. ed. Textbook of Veterinary Internal Medicine. 2nd ed.. Philadelphia: Saunders; 1983: 513-522
- 13 Walker S, Waddell W, Goodrowe K. Reproductive endocrine patterns in captive female and red wolfes (Canis rufus) assessed by fecal and hormone analysis. Zoo Biol 2002; 21: 321-335
- 14 Carlson D, Gese E. Reproductive biology of the coyote (Canis latrans): ingegration of mating behavior, reproductive hormones, and vaginal cytology. J Mammalogy 2008; 89: 654-664
- 15 Van der Weyde LK, Martin GB, Blackberry MA. et al. Reproductive hormonal pattern in pregnant, pseudopregnant and acyclic captive African wild dogs (Lycaon pitus). Anim Reprod Sci 2015; 156: 75-82
- 16 Hardley JC. Unconjugated oestrogen and progesterone concentrations in the blood of bitches with false pregnancy and pyometra. Vet Rec 1975; 96: 545-547
- 17 Arbeiter K, Winding W. On the treatment of lactatio sine graviditate and postpartum lactic congestion with the antiprolactin 2-Br-ergocryptin α. J Small Anim Pract 1977; 22: 271-278
- 18 Johnston SD. False pregnancy in the bitch. In: Morrow DA. ed. Current Veterinary Theriogenology. Philadelphia: Saunders; 1980: 623-624
- 19 Okkens AC, Diekman SJ, Kooistra HS. et al. Plasma concentrations of prolactin in overtly pseudopregnant Afghan hounds and the effect of metergoline. J Reprod Fertil 1997; 51: 295-301
- 20 Bastan A, Findik M, Erunal N. et al. The use of cabergoline for treatment of pseudopregnancy in dogs with the purpose of suppressing lactation. Reprod Domest Anim 1998; 33: 49-53
- 21 Gobello C, de la Sota RL, Goya RG. A review of canine pseudocyesis. Reprod Domest Anim 2001; 36: 283-288
- 22 Özyurtlu N, Ay SS, Alacom E. Evaluation of vaginal smears, progesterone and relaxin levels in pregnant, and overt and covert pseudopregnant bitches. Turk J Vet Anim Sci 2006; 30: 465-470
- 23 Harvey MJ, Dale MJ, Lindley S. et al. A study of the aetiology of pseudopregnancy in the bitch and the effect of cabergoline therapy. Vet Rec 1999; 144: 433-436
- 24 Gobello C, Combani M, Scaglia H. et al. Heterogeneity of circulating prolactin in the bitch. Reprod Nutr Dev 2001; 41: 505-511
- 25 Tsutsui T, Kirihara N, Hori T. et al. Plasma progesterone and prolactin concentrations on overtly pseudopregnant bitches: A clinical study. Theriogenology 2006; 67: 1032-1038
- 26 Bostedt H. Lactatio sine graviditate – Pseudogravidität. In: Günzel-Apel AR, Bostedt H. Hrsg. Reproduktionsmedizin und Neonatologie von Hund und Katze. Stuttgart: Schattauer; 2016: 103-108
- 27 Root AL, Parkin TD, Hutchison P. et al. Canine pseudopregnancy: an evaluation of prevalence and current treatment protocols in the UK. BMC Vet Res 2018; 14: 170-180
- 28 Thangamani A, Srinivas M, Chandra Prasad AK. et al. Canine Pseudopregnancy A Review. J Vet Sci Technol 2018; 7: 7-11
- 29 Grünau B, Nolte I, Hoppen HO. Untersuchung zur Behandlung der Scheinträchtigkeit der Hündin mit den Prolaktinhemmern Metergolin und Bromocryptin. Tierarztl Prax 1996; 24: 149-155
- 30 Onclin K, Verstegen JP. Secretion patterns of plasma prolactin and progesterone in pregnant compared with nonpregnant dioestrous beagle bitches. J Reprod Fertil 1997; 51: 203-208
- 31 Tammer I, Blendinger K, Sobiraj A. et al. Über den Einsatz der exfoliativen Vaginalzytologie im Rahmen der gynäkologischen Befunderhebung bei der Hündin. Tierarztl Prax 1994; 22: 199-207
- 32 Dixon WJ. BMDP statistical software, BMDP/DYNAMIC release 7.0. University of California Press; 1993. Berkeley, CA:
- 33 Mehta C, Patel N. StatXact-Turbo, Cytel Software Corp. Cambridge, Massachusetts: 1992
- 34 Janssen LAA. Treatment of pseudopregnancy with bromocriptin, an ergot alkaloid. Vet Rec 1986; 119: 172-174
- 35 Arbeiter K, Hofmann E, Rüsse M. et al. Metergolin zur Behandlung von Pseudogravidität und Laktationsunterbrechung bei der Hündin. Kleintierprax 1995; 40: 421-429
- 36 El Etreby MF, Wrobel KH. Effect of cyproterone acetat, al-norgestrol and progesterone on the canine mammary gland. Cell Tissue Res 1978; 194: 2445-267
- 37 Bostedt H, Jung C, Wehrend A. et al. Klinische und endokrinologische Befunde von Hündinnen mit Ovarialzystensyndrom. Schweiz Arch Tierheilk 2013; 155: 543-550
- 38 Knauf Y, Bostedt H, Failing K. et al. Gross pathology and endrocrinology of ovarian cysts in bitches. Reprod Domest Anim 2014; 49: 463-468
- 39 Beijerink NJ, Dieleman SJ, Kooistra HS. et al. Low doses of bromocriptin shorten the interestrous interval in the bitsch without lowering plasma prolactin concentration. Theriogenology 2003; 60: 1379-1383